Almac Group announces £11m investment to expand global analytical services
Learn more
Almac Group announces £11m investment to expand global analytical services
Learn more
Almac Group’s power purchase agreement for renewable energy is now live
Carbon emissions from electricity consumed
at our Northern Ireland headquarters will be reduced by 95%
Learn more
Your trusted CDMO
Now and into the future
Learn more
Almac announces completion of two new facilities as part of £400m expansion
Read more
Almac Group releases 2023 Corporate Social Responsibility Report
Read more
Want to play a part in advancing human health?
Join us
Almac Group is proud of its global reputation for excellence, delivering expertise right across the drug development lifecycle and offering a tailored solution to each client.
Our client relationships are long term and they are underpinned by one simple commitment:
We will be exceptional, always.
7500
Employees globally
50%+
Contributed to over half of approved NMEs in the last 6 years
55+
Years’ experience
25
Work with top 25 BioPharma companies
18
Facilities globally
Latest from Almac
Partnering to advance human health
Explore our locationsAlmac Discovery
Almac Discovery is a research driven drug discovery company dedicated to the development of novel and innovative therapeutics using cutting edge research techniques to develop First in Class preclinical stage assets.
Find out more
Diagnostic Services
Almac Diagnostic Services is our precision medicine business unit, supporting global pharma and biotech companies to deliver on their biomarker strategies.
Find out more
Pharmaceutical Development & Manufacturing Services
We are trusted experts in API Manufacture, Formulation Development, Clinical Trial Supply Services and Technologies through to Commercial-Scale Manufacture and Distribution.
Find out more
Developing and marketing pharmaceuticals globally
Galen, part of the Almac Group, is a global pharmaceutical company selling medicines worldwide, and partners with like-minded companies to accomplish this.
Find out more